Opportunity Information: Apply for CDC RFA GH15 1542
Apply for CDC RFA GH15 1542
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Enhancing the Government of Indias Capacity through PEPFAR to Scale Up and Improve Comprehensive HIV Service Package Quality for People Who Inject Drugs under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Aug 28, 2014 and posted on Aug 28, 2014.
- Applicants must submit their applications by Oct 15, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,800,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this FOA are listed below Government Organizations National Ministries of Health State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . American Indian/Alaska Native tribal governments (federally recognized or state recognized) Political subdivisions of States (in consultation with States) Non government Organizations American Indian/Alaska native tribally designated organizations Alaska Native health corporations Tribal epidemiology centers Urban Indian health organizations Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Research institutions (that will perform activities deemed as non research) Colleges and Universities Community based organizations Faith based organizations For profit organizations (other than small business) Hospitals Small, minority, and women owned businesses All Other eligible organizations
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC cooperative agreement funding opportunity (CDC RFA GH15-1542) supports work under the US President's Emergency Plan for AIDS Relief (PEPFAR) to strengthen the Government of India's capacity to scale up and improve the quality of a comprehensive HIV service package for people who inject drugs (PWID). The core problem driving the award is that, even after major expansion of interventions, HIV prevalence among PWID in India remains high at about 7.1 percent, with especially alarming levels in the North Eastern states where the epidemic is more concentrated, including Manipur (12.9 percent), Mizoram (12.0 percent), and Meghalaya (6.4 percent). The opportunity is framed around closing persistent gaps in coverage, intensity, and service quality in these settings, where stigma, discrimination, and limited provider skills continue to keep people from accessing effective prevention, testing, and treatment services.
The announcement points to specific evidence of program weaknesses. A 2011 qualitative study highlighted that PWID interventions, particularly in the North East, were lagging in both intensity and reach, and that PWID faced ongoing barriers such as stigma and discrimination in health and community settings. The same study noted an important shift in drug use patterns, with many individuals moving from non-injecting routes (such as smoking or chasing heroin) to injecting practices, including injecting pharmaceuticals or heroin, which can raise HIV risk when sterile equipment and harm reduction services are not consistently available. National program data cited in the announcement underscores underperformance in key services: opioid substitution therapy (OST) coverage in the North East was reported as 12 against a planned target of 20, retention in OST was low at 59, and HIV testing coverage was also low at 48. Together, these figures signal that the pipeline from outreach to testing to sustained treatment for substance use and HIV prevention is not functioning at the needed scale or quality, especially where the epidemic burden is highest.
A major emphasis is also placed on populations that are undercounted or underserved within PWID programming. The opportunity notes scant information on the extent of female PWID and the specific challenges they face in accessing services, despite an estimated 10,000 female PWID concentrated in the North East. Available HIV testing facility data suggests HIV prevalence among female PWID ranges roughly from 7 to 25, indicating potentially severe localized epidemics and highlighting the need for more tailored approaches that address gender-specific barriers. In addition, the announcement raises concerns about HIV risk within families and intimate partnerships, reporting elevated HIV prevalence among spouses of PWID (about 2.5 to 5) and high levels of reported spousal violence (55). These points signal an expectation that strengthening the PWID service package should not only focus on the individual injector, but also consider partner risk, safety, and related social harms that can undermine prevention and engagement in care.
Administratively, this is a discretionary funding opportunity from the Centers for Disease Control and Prevention (CDC) using a cooperative agreement mechanism, meaning CDC would typically have substantial involvement in program planning, technical guidance, and performance monitoring compared with a standard grant. The activity category is health, and the CFDA number listed is 93.067 (Global AIDS). The posting date was August 28, 2014, with an original and current closing date of October 15, 2014, and an archive date of November 14, 2014. The award ceiling is listed as $1,800,000, with an expected number of awards of 1, and no cost sharing or matching requirement.
Eligibility is broad and includes government organizations (such as national ministries of health and state or local governments or their bona fide agents), tribal governments and related health entities, and a wide range of nongovernmental organizations. This includes nonprofits with or without 501(c)(3) status, research institutions conducting non-research activities, colleges and universities, community-based and faith-based organizations, for-profit organizations (other than small businesses), hospitals, and small/minority/women-owned businesses, among others. The overall intent is to enable a capable implementing partner to work with government systems and frontline services to expand and improve the comprehensive package for PWID, with particular attention to the North Eastern states, service quality and provider capacity, improved access and uptake of testing and OST, and better responses for women who inject drugs and spouses or partners affected by HIV risk and violence.
For technical issues accessing the full announcement, the notice provides CDC Procurement and Grants Office Technical Information Management Section contact details (pgotim@cdc.gov; 770-488-2700).
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is a CDC cooperative agreement funding opportunity, identified as CDC RFA GH15-1542, supporting work under the US President's Emergency Plan for AIDS Relief (PEPFAR). It focuses on strengthening the Government of India's capacity to scale up and improve the quality of a comprehensive HIV service package for people who inject drugs (PWID).
What problem is this award trying to address?
The award is driven by persistently high HIV prevalence among PWID in India even after major expansion of interventions. The announcement highlights ongoing gaps in coverage, intensity, and service quality, particularly in areas where stigma, discrimination, and limited provider skills reduce access to effective prevention, testing, and treatment services.
Which locations are emphasized in the announcement?
The opportunity places particular emphasis on the North Eastern states of India, where the epidemic among PWID is more concentrated and HIV prevalence levels are described as especially alarming, including Manipur (12.9 percent), Mizoram (12.0 percent), and Meghalaya (6.4 percent).
What HIV prevalence levels are cited for PWID in India?
The announcement cites an HIV prevalence of about 7.1 percent among PWID in India overall, with higher prevalence in specific North Eastern states (for example, Manipur at 12.9 percent and Mizoram at 12.0 percent).
What program weaknesses or service gaps does the announcement point to?
The announcement references evidence that PWID interventions (particularly in the North East) were lagging in intensity and reach, and that PWID continue to face barriers such as stigma and discrimination in health and community settings. It also cites underperformance in key services, including opioid substitution therapy (OST) coverage and retention and HIV testing coverage.
What specific service performance figures are mentioned?
National program data cited in the announcement includes: OST coverage in the North East reported as 12 against a planned target of 20, retention in OST reported as 59, and HIV testing coverage reported as 48.
Why does the announcement discuss changes in drug use patterns?
The announcement notes a shift in drug use patterns, with many individuals moving from non-injecting routes (such as smoking or chasing heroin) to injecting practices, including injecting pharmaceuticals or heroin. This shift can increase HIV risk when sterile equipment and harm reduction services are not consistently available.
Who is the primary population of focus for program activities?
The primary focus is people who inject drugs (PWID) in India, with particular attention to those in higher-burden North Eastern states and to persistent barriers that reduce access and quality of HIV prevention, testing, and treatment services.
Does the opportunity highlight any underserved sub-populations within PWID programming?
Yes. The announcement highlights limited information and potential undercounting/underserving of female PWID, including an estimate of about 10,000 female PWID concentrated in the North East, and it emphasizes the need for more tailored approaches to address gender-specific barriers.
What HIV burden indicators are mentioned for female PWID?
Based on available HIV testing facility data referenced in the announcement, HIV prevalence among female PWID is described as ranging roughly from 7 to 25, suggesting potentially severe localized epidemics and a need for tailored program responses.
Does the announcement mention risks affecting spouses or partners of PWID?
Yes. The announcement raises concerns about HIV risk within families and intimate partnerships. It reports elevated HIV prevalence among spouses of PWID (about 2.5 to 5) and high levels of reported spousal violence (55).
How does the announcement frame the expected scope of the comprehensive PWID service package?
The opportunity frames the work around closing gaps in coverage, intensity, and service quality for PWID services, and it signals that efforts should consider not only the individual injector but also partner risk, safety, and related social harms that can undermine prevention and engagement in care.
What is the funding mechanism?
The mechanism is a cooperative agreement, which typically means CDC has substantial involvement in program planning, technical guidance, and performance monitoring compared with a standard grant.
Which federal agency is offering this opportunity?
The opportunity is offered by the Centers for Disease Control and Prevention (CDC).
What is the activity category and CFDA number?
The activity category is health. The CFDA number listed is 93.067 (Global AIDS).
What are the key dates for this opportunity?
The posting date was August 28, 2014. The original and current closing date was October 15, 2014. The archive date was November 14, 2014.
How much funding is available, and how many awards are expected?
The award ceiling is listed as $1,800,000. The expected number of awards is 1.
Is cost sharing or matching required?
No cost sharing or matching requirement is listed for this opportunity.
Who is eligible to apply?
Eligibility is broad and includes government organizations (such as national ministries of health and state or local governments or their bona fide agents), tribal governments and related health entities, and a wide range of nongovernmental organizations. Examples listed include nonprofits with or without 501(c)(3) status, research institutions conducting non-research activities, colleges and universities, community-based and faith-based organizations, for-profit organizations (other than small businesses), hospitals, and small/minority/women-owned businesses, among others.
Are for-profit organizations eligible?
Yes. The announcement includes for-profit organizations as eligible applicants, specifically noting for-profit organizations other than small businesses.
What type of implementing approach does the opportunity appear to anticipate?
Based on the description, the opportunity is intended to enable a capable implementing partner to work with government systems and frontline services to expand and improve the comprehensive package for PWID, with attention to the North Eastern states, service quality and provider capacity, improved access and uptake of HIV testing and OST, and improved responses for women who inject drugs and spouses or partners affected by HIV risk and violence.
What barriers to service access are specifically mentioned?
The announcement specifically mentions stigma and discrimination, along with limited provider skills, as factors that continue to keep people from accessing effective prevention, testing, and treatment services.
What should applicants do if they have technical issues accessing the full announcement?
For technical issues accessing the full announcement, the notice provides CDC Procurement and Grants Office Technical Information Management Section contact details: pgotim@cdc.gov and 770-488-2700.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Training Modules to Enhance Data Reproducibility (R25)
Previous opportunity: Biomarkers of Alzheimers Disease in Down Syndrome (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1542
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1542) also looked into and applied for these:
| Funding Opportunity |
|---|
| Administrative Supplements for U.S. Brazil Biomedical Collaborative Research Apply for PA 14 328 Funding Number: PA 14 328 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Implementation of Sustainable Laboratory Quality Systems in the Republic of Kenya under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1544 Funding Number: CDC RFA GH15 1544 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $15,000,000 |
| Quality Data for Decision Making (QDDM) Apply for APS 386 14 000002 Funding Number: APS 386 14 000002 Agency: India USAID New Delhi Category: Health Funding Amount: $6,000,000 |
| Implementing Evidence Based Prevention Interventions for Key Populations in the Republic of Rwanda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1616 Funding Number: CDC RFA GH15 1616 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,360,627 |
| Building Institutional Capacity to Improve HIV TB Care and Treatment Service Quality in India under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1540 Funding Number: CDC RFA GH15 1540 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $750,000 |
| Expand Coverage and Improve the Quality of Facility and Community Based Prevention of Mother to Child Transmission of HIV (PMTCT) Support for Rollout of Option B Services in the Littoral and Center Regions of Cameroon under the Presidents Emergency P Apply for CDC RFA GH15 1508 Funding Number: CDC RFA GH15 1508 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,000,000 |
| Limited Competition Strategic Timing of Antiretroviral Treatment (START) (UM1) Apply for PAR 14 329 Funding Number: PAR 14 329 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Surveillance, Service Data Analysis and Capacity Building to Support Management, Leadership and Sustainability of HIV Programs in Haiti and other Health Initiatives under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1529 Funding Number: CDC RFA GH15 1529 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,250,000 |
| Guyana Civil Society Leadership Project Apply for RFA 538 14 000007 Funding Number: RFA 538 14 000007 Agency: Dominican Republic USAID Santo Domingo Category: Health Funding Amount: $500,000 |
| Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Formula Grant Program Apply for HRSA 15 101 Funding Number: HRSA 15 101 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Program Grants Apply for HRSA 15 102 Funding Number: HRSA 15 102 Agency: Health Resources and Services Administration Category: Health Funding Amount: $9,400,000 |
| NIMH Career Transition Award for Tenure Track and Tenured Intramural Investigators (K22) Apply for PAR 14 330 Funding Number: PAR 14 330 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening of the Human Resources Information System and Development of Open Health Information Enterprise Architecture in the Republic of Zimbabwe under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1604 Funding Number: CDC RFA GH15 1604 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Enhancing Strategic Information Capacity for HIV/AIDS Programs in Kenya through Surveillance and Epidemiology, Monitoring and Evaluation and Mobile Health Solutions under the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1543 Funding Number: CDC RFA GH15 1543 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $9,800,000 |
| Comprehensive High Impact HIV Prevention Projects for Community Based Organizations Apply for CDC RFA PS15 1502 Funding Number: CDC RFA PS15 1502 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $450,000 |
| Strengthening Laboratory and Blood Transfusion Services in South Sudan under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1571 Funding Number: CDC RFA GH15 1571 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,200,000 |
| Information System Development and Systems Integration Support for National HIV and Health Sector Systems in the Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1586 Funding Number: CDC RFA GH15 1586 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $900,000 |
| Partnership for State Title V Maternal and Child Health Leadership Community Cooperative Agreement Apply for HRSA 15 071 Funding Number: HRSA 15 071 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,537,500 |
| Planning Grants for Dental, Oral and Craniofacial Tissue Regeneration Consortium Resource Centers (R34) Apply for RFA DE 15 005 Funding Number: RFA DE 15 005 Agency: National Institutes of Health Category: Health Funding Amount: $125,000 |
| National State Based Tobacco Control Programs Apply for CDC RFA DP15 1509 Funding Number: CDC RFA DP15 1509 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $23,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1542", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.